Anzahl der Publikationen: 11
2023
Ho, Samantha; Oswald, Eva; Wong, Hoi Kiu; Vural, Atay; Yilmaz, Vuslat; Tuezuen, Erdem; Tuerkoglu, Recai; Straub, Tobias; Meinl, Ingrid; Thaler, Franziska; Kuempfel, Tania; Meinl, Edgar und Mader, Simone
(2023):
Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis.
In: Neurology-Neuroimmunology & Neuroinflammation, Bd. 10, Nr. 2, e200083
[PDF, 731kB]
2021
Graf, Jonas; Leussink, Verena I.; Soncin, Giulia; Lepka, Klaudia; Meinl, Ingrid; Kumpfel, Tania; Meuth, Sven G.; Hartung, Hans-Peter; Havla, Joachim; Aktas, Orhan und Albrecht, Philipp
(2021):
Relapse-independent multiple sclerosis progression under natalizumab.
In: Brain Communications, Bd. 3, Nr. 4, fcab229
Kuempfel, Tania; Thiel, Sandra; Meinl, Ingrid; Ciplea, Andrea I.; Bayas, Antonios; Hoffmann, Frank; Hofstadt-van Oy, Ulrich; Hoshi, Muna; Kluge, Jakob; Ringelstein, Marius; Aktas, Orhan; Stoppe, Muriel; Walter, Annette; Weber, Martin S.; Ayzenberg, Ilya und Hellwig, Kerstin
(2021):
Anti-CD20 therapies and pregnancy in neuroimmunologic disorders A cohort study from Germany.
In: Neurology-Neuroimmunology & Neuroinflammation, Bd. 8, Nr. 1, e913
Schlüter, Miriam; Oswald, Eva; Winklmeier, Stephan; Meinl, Ingrid; Havla, Joachim; Eichhorn, Peter; Meinl, Edgar und Kümpfel, Tania
(2021):
Effects of Natalizumab Therapy on Intrathecal Immunoglobulin G Production Indicate Targeting of Plasmablasts.
In: Neurology-Neuroimmunology & Neuroinflammation, Bd. 8, Nr. 5, e1030
2020
Mulazzani, Elisabeth; Wagner, Danny; Havla, Joachim; Schlueter, Miriam; Meinl, Ingrid; Gerdes, Lisa-Ann und Kuempfel, Tania
(2020):
Neurological phenotypes in patients with NLRP3-, MEFV-, and TNFRSF1A low-penetrance variants.
In: Journal of Neuroinflammation, Bd. 17, Nr. 1, 196
[PDF, 1MB]
2019
Schwab, Nicholas; Schneider-Hohendorf, Tilman; Pignolet, Beatrice; Bucciarelli, Florence; Scandella, Lise; Ciron, Jonathan; Biotti, Damien; Lebrun-Frenay, Christine; Mathey, Guillaume; Clavelou, Pierre; Pelletier, Jean; Ostkamp, Patrick; Meinl, Ingrid; Windhagen, Susanne; Klotz, Luisa; Gross, Catharina C.; Meuth, Sven G.; Deisenhammer, Florian; Brassat, David; Wiendl, Heinz; Martinez, Maria; Heinzlef, Olivier; Zephir, Helene; Anne, Olivier; Audoin, Bertrand; Bensa, Caroline; Berger, Eric; Cabre, Philippe; Castelnovo, Giovanni; Collongues, Nicolas; Coustans, Marc; Creange, Alain; Dive, Dominique; Edan, Gilles; Fromont, Agnes; Gout, Olivier; Gouider, Riadh; Grimaud, Jerome; Hautecoeur, Patrick; Kiatkoswki, Arnaud; LePage, Emmanuelle; Marignier, Romain; Moreau, Thibault; Ouallet, Jean-Christophe; Papeix, Caroline; Rumbach, Lucien; Seeldrayers, Pierrette; Sennou, Ilham Slassi; Stankoff, Bruno; Tourbah, Ayman; Thouvenot, Eric und Vermersch, Patrick
(2019):
Prospective validation of the PML risk biomarker L-selectin and influence of natalizumab extended intervals.
In: Neurology, Bd. 93, Nr. 12: S. 550-554
2018
2016
Schuh, Elisabeth; Berer, Kerstin; Mulazzani, Matthias; Feil, Katharina; Meinl, Ingrid; Lahm, Harald; Krane, Markus; Lange, Rüdiger; Pfannes, Kristina; Subklewe, Marion; Gürkov, Robert; Bradl, Monika; Hohlfeld, Reinhard; Kümpfel, Tania; Meinl, Edgar und Krumbholz, Markus
(2016):
Features of Human CD3(+)CD20(+) T Cells.
In: Journal of Immunology, Bd. 197, Nr. 4: S. 1111-1117
Schwab, Nicholas; Schneider-Hohendorf, Tilman; Pignolet, Béatrice; Spadaro, Michela; Görlich, Dennis; Meinl, Ingrid; Windhagen, Susanne; Tackenberg, Björn; Breuer, Johanna; Cantó, Ester; Kümpfel, Tania; Hohlfeld, Reinhard; Siffrin, Volker; Luessi, Felix; Posevitz-Fejfár, Anita; Montalban, Xavier; Meuth, Sven G.; Zipp, Frauke; Gold, Ralf; Du Pasquier, Renaud A.; Kleinschnitz, Christoph; Jacobi, Annett; Comabella, Manuel; Bertolotto, Antonio; Brassat, David und Wiendl, Heinz
(2016):
PML risk stratification using anti-JCV antibody index and L-selectin.
In: Multiple Sclerosis Journal, Bd. 22, Nr. 8: S. 1048-1060
[PDF, 1MB]
2014
Hoepner, Robert; Havla, Joachim; Eienbröker, Christian; Tackenberg, Björn; Hellwig, Kerstin; Meinl, Ingrid; Hohlfeld, Reinhard; Gold, Ralf; Kümpfel, Tania und Kleiter, Ingo
(2014):
Predictors for multiple sclerosis relapses after switching from natalizumab to fingolimod.
In: Multiple Sclerosis Journal, Bd. 20, Nr. 13: S. 1714-1720
[PDF, 115kB]
Diese Liste wurde am
Sat Dec 21 22:54:54 2024 CET
erstellt.